Rhythmic oscillations of the microrna mir-96-5p play a neuroprotective role by indirectly regulating glutathione levels

Nature Communications

Volumn 5, Issue , 2014, Pages

  Kinoshita, Chisato ^a   Aoyama, Koji ^a   Matsumura, Nobuko ^a   Kikuchi Utsumi, Kazue ^a   Watabe, Masahiko ^a   Nakaki, Toshio ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; GLUTATHIONE; GLUTATHIONE DISULFIDE; MICRORNA; MICRORNA 96 5P; UNCLASSIFIED DRUG; ANTIOXIDANT; MIRN96 MICRORNA, HUMAN; NEUROPROTECTIVE AGENT; SLC1A1 PROTEIN, HUMAN;

AMINO ACID; ANTIOXIDANT; BRAIN; CORRELATION; DISEASE INCIDENCE; NEUROLOGY; RODENT;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN; CELL LINE; DEGENERATIVE DISEASE; GENETICS; HEK293 CELL LINE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BRAIN; CELL LINE; CIRCADIAN RHYTHM; DOPAMINERGIC NEURONS; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTATHIONE; HEK293 CELLS; HUMANS; MALE; MICE; MICRORNAS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; SUBSTANTIA NIGRA;

EID: 84900018024     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4823     Document Type: Article

References (47)

1. Henchcliffe, C. & Beal, M. F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4, 600-609 (2008).
2. Finkel, T. & Holbrook, N. J. Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247 (2000).
3. Dringen, R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671 (2000).
4. Sian, J. et al. Alterations in glutathione levels in Parkinsons disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355 (1994).
5. Aoyama, K., Watabe, M. & Nakaki, T. Regulation of neuronal glutathione synthesis. J. Pharmacol. Sci. 108, 227-238 (2008).
6. Maragakis, N. J. & Rothstein, J. D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15, 461-473 (2004).
7. Rothstein, J. D. et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686 (1996).
8. Aoyama, K. et al. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9, 119-126 (2006).
9. Berman, A. E. et al. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/-mouse. Ann. Neurol. 69, 509-520 (2011).
10. Bass, J. Circadian topology of metabolism. Nature 491, 348-356 (2012).
11. Kondratov, R. V. A role of the circadian system and circadian proteins in aging. Ageing Res. Rev. 6, 12-27 (2007).
12. Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V. & Antoch, M. P. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev. 20, 1868-1873 (2006).
13. Willison, L. D., Kudo, T., Loh, D. H., Kuljis, D. & Colwell, C. S. Circadian dysfunction may be a key component of the non-motor symptoms of Parkinsons disease: insights from a transgenic mouse model. Exp. Neurol. 243, 57-66 (2013).
14. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
15. Cheng, H. Y. & Obrietan, K. Revealing a role of microRNAs in the regulation of the biological clock. Cell Cycle 6, 3034-3035 (2007).
16. Reddy, A. B. et al. Circadian orchestration of the hepatic proteome. Curr. Biol. 16, 1107-1115 (2006).
17. Harraz, M. M., Dawson, T. M. & Dawson, V. L. MicroRNAs in Parkinsons disease. J. Chem. Neuroanat. 42, 127-130 (2011).
18. Calcutt, G. Diurnal variations in rat blood glutathione levels. Naturwissenschaften 54, 120 (1967).
19. Filipski, E. et al. Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R844-R851 (2004).
20. Blanco, R. A. et al. Diurnal variation in glutathione and cysteine redox states in human plasma. Am. J. Clin. Nutr. 86, 1016-1023 (2007).
21. Lach, H., Surowiak, J., Dziubek, K., Krawczyk, S. & Szaroma, W. Cosinor analysis of diurnal changes of the reduced glutathione level in the blood, brain, liver and kidneys of mice, induced by ACTH administration. Acta Biol. Hung. 37, 93-100 (1986).
22. Farooqui, M. Y. & Ahmed, A. E. Circadian periodicity of tissue glutathione and its relationship with lipid peroxidation in rats. Life Sci. 34, 2413-2418 (1984).
23. Baydas, G. et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci. Lett. 323, 195-198 (2002).
24. Balsalobre, A., Damiola, F. & Schibler, U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93, 929-937 (1998).
25. Akashi, M. & Nishida, E. Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes Dev. 14, 645-649 (2000).
26. Watabe, M., Aoyama, K. & Nakaki, T. Regulation of glutathione synthesis via interaction between glutamate transport-associated protein 3-18 (GTRAP3-18) and excitatory amino acid carrier-1 (EAAC1) at plasma membrane. Mol. Pharmacol. 72, 1103-1110 (2007).
27. Aoyama, K. et al. Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice. Neurobiol. Dis. 45, 973-982 (2012).
28. Sena, L. A. & Chandel, N. S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158-167 (2012).
29. Dickinson, B. C. & Chang, C. J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 7, 504-511 (2011).
30. Arjona, A. & Sarkar, D. K. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J. Immunol. 174, 7618-7624 (2005).
31. Kochman, L. J., Weber, E. T., Fornal, C. A. & Jacobs, B. L. Circadian variation in mouse hippocampal cell proliferation. Neurosci. Lett. 406, 256-259 (2006).
32. Ma, D., Panda, S. & Lin, J. D. Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J. 30, 4642-4651 (2011).
33. Kondratova, A. A., Dubrovsky, Y. V., Antoch, M. P. & Kondratov, R. V. Circadian clock proteins control adaptation to novel environment and memory formation. Aging (Albany NY) 2, 285-297 (2010).
34. Beaver, L. M. et al. Circadian regulation of glutathione levels and biosynthesis in Drosophila melanogaster. PLoS ONE 7, e50454 (2012).
35. Xu, Y. Q. et al. Diurnal variation of hepatic antioxidant gene expression in mice. PLoS ONE 7, e44237 (2012).
36. Krishnan, N., Davis, A. J. & Giebultowicz, J. M. Circadian regulation of response to oxidative stress in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 374, 299-303 (2008).
37. Pablos, M. I. et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int. 32, 69-75 (1998).
38. Jomova, K., Vondrakova, D., Lawson, M. & Valko, M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem. 345, 91-104 (2010).
39. Sofic, E., Lange, K. W., Jellinger, K. & Riederer, P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinsons disease. Neurosci. Lett. 142, 128-130 (1992).
40. Perry, T. L., Godin, D. V. & Hansen, S. Parkinsons disease: a disorder due to nigral glutathione deficiency Neurosci. Lett. 33, 305-310 (1982).
41. Tomita, J., Nakajima, M., Kondo, T. & Iwasaki, H. No transcription-translation feedback in circadian rhythm of KaiC phosphorylation. Science 307, 251-254 (2005).
42. Nakajima, M. et al. Reconstitution of circadian oscillation of cyanobacterial KaiC phosphorylation in vitro. Science 308, 414-415 (2005).
43. ONeill, J. S. & Reddy, A. B. Circadian clocks in human red blood cells. Nature 469, 498-503 (2011).
44. Kondratov, R. V., Vykhovanets, O., Kondratova, A. A. & Antoch, M. P. Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging (Albany NY) 1, 979-987 (2009).
45. Aoyama, K., Matsumura, N., Watabe, M. & Nakaki, T. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur. J. Neurosci. 27, 20-30 (2008).
46. Matsumura, N. et al. Anticonvulsant action of indazole. Epilepsy Res. 104, 203-216 (2013).
47. Watabe, M., Aoyama, K. & Nakaki, T. A dominant role of GTRAP3-18 in neuronal glutathione synthesis. J Neurosci. 28, 9404-9413 (2008).